• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Emerging permanent filler technologies: focus on Aquamid.新兴的永久性填充技术:聚焦 Aquamid。
Clin Cosmet Investig Dermatol. 2014 Oct 10;7:261-6. doi: 10.2147/CCID.S46650. eCollection 2014.
2
Soft tissue filler and botulinum toxin treatment techniques.软组织填充剂和肉毒毒素治疗技术。
G Ital Dermatol Venereol. 2012 Feb;147(1):29-44.
3
Efficacy and safety of polyacrylamide hydrogel for facial soft-tissue augmentation.聚丙烯酰胺水凝胶用于面部软组织填充的疗效与安全性。
Plast Reconstr Surg. 2005 Sep 15;116(4):1137-46; discussion 1147-8. doi: 10.1097/01.prs.0000179349.14392.a4.
4
A 5-year assessment of safety and aesthetic results after facial soft-tissue augmentation with polyacrylamide hydrogel (Aquamid): a prospective multicenter study of 251 patients.251 例患者前瞻性多中心研究:聚丙烯酰胺水凝胶(爱贝芙)面部软组织填充 5 年的安全性和美学效果评估。
Plast Reconstr Surg. 2010 Jun;125(6):1797-1804. doi: 10.1097/PRS.0b013e3181d18158.
5
Adverse reactions to injectable soft tissue permanent fillers.可注射软组织永久性填充剂的不良反应。
Aesthetic Plast Surg. 2005 Jan-Feb;29(1):34-48. doi: 10.1007/s00266-004-0113-6. Epub 2005 Mar 11.
6
Selection and preference for botulinum toxins in the management of photoaging and facial lines: patient and physician considerations.肉毒杆菌毒素在光老化和面部皱纹治疗中的选择与偏好:患者和医生的考量因素
Patient Prefer Adherence. 2010 Sep 7;4:345-54. doi: 10.2147/ppa.s6494.
7
Use of Aquamid as a filler for facial rejuvenation in orientals.将 Aquamid 用作东方人面部年轻化的填充物。
J Plast Reconstr Aesthet Surg. 2009 Oct;62(10):1245-9. doi: 10.1016/j.bjps.2008.03.042. Epub 2009 Mar 20.
8
Efficacy and safety of polyacrylamide hydrogel for facial soft-tissue augmentation in a 2-year follow-up: a prospective multicenter study for evaluation of safety and aesthetic results in 101 patients.聚丙烯酰胺水凝胶用于面部软组织填充两年随访的疗效与安全性:一项评估101例患者安全性及美学效果的前瞻性多中心研究
Plast Reconstr Surg. 2006 Sep;118(3 Suppl):85S-91S. doi: 10.1097/01.prs.0000234844.59251.3f.
9
The role of hyaluronic acid fillers (Restylane) in facial cosmetic surgery: review and technical considerations.透明质酸填充剂(瑞蓝)在面部整形手术中的作用:综述与技术考量
Plast Reconstr Surg. 2007 Nov;120(6 Suppl):41S-54S. doi: 10.1097/01.prs.0000248794.63898.0f.
10
Principles of soft tissue augmentation for the aging face.衰老面部软组织填充的原则。
Clin Interv Aging. 2006;1(4):349-55. doi: 10.2147/ciia.2006.1.4.349.

引用本文的文献

1
Injectable fillers: current status, physicochemical properties, function mechanism, and perspectives.可注射填充剂:现状、物理化学性质、作用机制及展望。
RSC Adv. 2023 Aug 10;13(34):23841-23858. doi: 10.1039/d3ra04321e. eCollection 2023 Aug 4.
2
Antimicrobial-Loaded Polyacrylamide Hydrogels Supported on Titanium as Reservoir for Local Drug Delivery.负载抗菌剂的聚丙烯酰胺水凝胶负载于钛上作为局部药物递送的储库。
Pathogens. 2023 Jan 28;12(2):202. doi: 10.3390/pathogens12020202.
3
A Polymer Prodrug Strategy to Switch from Intravenous to Subcutaneous Cancer Therapy for Irritant/Vesicant Drugs.聚合物前药策略将刺激性/腐蚀性药物的给药途径从静脉注射改为皮下注射用于癌症治疗。
J Am Chem Soc. 2022 Oct 19;144(41):18844-18860. doi: 10.1021/jacs.2c04944. Epub 2022 Oct 4.
4
Creating Complex Polyacrylamide Hydrogel Structures Using 3D Printing with Applications to Mechanobiology.使用 3D 打印技术创建复杂的聚丙烯酰胺水凝胶结构及其在机械生物学中的应用。
Macromol Biosci. 2020 Jul;20(7):e2000082. doi: 10.1002/mabi.202000082. Epub 2020 Jun 17.
5
Efficacy and safety of newly developed cross-linked dextran gel injection for glans penis augmentation with a novel technique.新型交联葡聚糖凝胶注射联合新技术用于阴茎头增大术的疗效与安全性
Asian J Androl. 2018 Jan-Feb;20(1):80-84. doi: 10.4103/aja.aja_1_17.
6
Fillers for the improvement in acne scars.用于改善痤疮疤痕的填充剂。
Clin Cosmet Investig Dermatol. 2015 Sep 29;8:493-9. doi: 10.2147/CCID.S86478. eCollection 2015.

本文引用的文献

1
Effect of prophylactic antibiotics on polyacrylamide gel safety in facial augmentation.预防性抗生素对面部填充聚丙烯酰胺凝胶安全性的影响。
J Drugs Dermatol. 2014 May;13(5):571-3.
2
Polylactic acid vs. polyacrylamide hydrogel for treatment of facial lipoatrophy: a randomized controlled trial [Agence Nationale de Recherches sur le SIDA et les Hépatites Virales (ANRS) 132 SMILE].聚乳酸对比聚丙烯酰胺水凝胶治疗面部脂肪萎缩:一项随机对照试验 [法国国家艾滋病和病毒性肝炎研究署 (ANRS) 132 SMILE]。
HIV Med. 2013 Aug;14(7):410-20. doi: 10.1111/hiv.12021. Epub 2013 Feb 24.
3
Bacterial infection as a likely cause of adverse reactions to polyacrylamide hydrogel fillers in cosmetic surgery.细菌感染可能是导致美容整形用聚丙烯酰胺水凝胶填充物不良反应的原因。
Clin Infect Dis. 2013 May;56(10):1438-44. doi: 10.1093/cid/cit067. Epub 2013 Feb 7.
4
Complications after polyacrylamide hydrogel injection for facial soft-tissue augmentation in China: twenty-four cases and their surgical management.中国聚丙烯酰胺水凝胶注射用于面部软组织填充后的并发症:24 例及其手术处理。
Plast Reconstr Surg. 2012 Aug;130(2):340e-348e. doi: 10.1097/PRS.0b013e3182589b7d.
5
Comparison between lipofilling and a nonabsorbable filler for facial wasting rehabilitation in HIV-positive patients.HIV阳性患者面部消瘦康复中脂肪填充与不可吸收填充剂的比较。
J Craniofac Surg. 2011 Sep;22(5):1684-8. doi: 10.1097/SCS.0b013e31822e5cf8.
6
Polyacrylamide gel injection for treatment of human immunodeficiency virus-associated facial lipoatrophy: 18 months follow-up.聚丙稀酰胺凝胶注射治疗人类免疫缺陷病毒相关性面部脂肪萎缩:18 个月随访。
Dermatol Surg. 2011 Nov;37(11):1584-9. doi: 10.1111/j.1524-4725.2011.02131.x. Epub 2011 Aug 1.
7
Polyacrylamide hydrogel injection in the management of human immunodeficiency virus-related facial lipoatrophy: results of the LIPOPHILL open-label study.聚丙烯酰胺水凝胶注射治疗人类免疫缺陷病毒相关面部脂肪萎缩:LIPOPHILL开放标签研究结果
AIDS Res Hum Retroviruses. 2012 Mar;28(3):251-8. doi: 10.1089/aid.2011.0042. Epub 2011 Aug 30.
8
Polyacrylamide gel for facial wasting rehabilitation: how many milliliters per session?用于面部消瘦康复的聚丙烯酰胺凝胶:每次治疗需要多少毫升?
Aesthetic Plast Surg. 2012 Feb;36(1):174-9. doi: 10.1007/s00266-011-9757-1. Epub 2011 Jun 3.
9
A 5-year assessment of safety and aesthetic results after facial soft-tissue augmentation with polyacrylamide hydrogel (Aquamid): a prospective multicenter study of 251 patients.251 例患者前瞻性多中心研究:聚丙烯酰胺水凝胶(爱贝芙)面部软组织填充 5 年的安全性和美学效果评估。
Plast Reconstr Surg. 2010 Jun;125(6):1797-1804. doi: 10.1097/PRS.0b013e3181d18158.
10
Unacceptable results with an accepted soft tissue filler: polyacrylamide hydrogel.接受的软组织填充剂:聚丙烯酰胺水凝胶出现不可接受的结果。
Aesthetic Plast Surg. 2010 Aug;34(4):413-22. doi: 10.1007/s00266-009-9359-3. Epub 2009 May 19.

新兴的永久性填充技术:聚焦 Aquamid。

Emerging permanent filler technologies: focus on Aquamid.

机构信息

Dermatology Institute and Skin Care Center, Santa Monica, CA, USA ; Division of Dermatology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

出版信息

Clin Cosmet Investig Dermatol. 2014 Oct 10;7:261-6. doi: 10.2147/CCID.S46650. eCollection 2014.

DOI:10.2147/CCID.S46650
PMID:25336982
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4199851/
Abstract

A plethora of soft tissue fillers have been developed within the past decade to correct the cutaneous changes that occur with photoaging. Such fillers, whether nonpermanent, semipermanent, or permanent, are widely used to fill undesired facial rhytides. In addition, fillers are employed to correct atrophy of the face as well as other parts of the body such as the dorsum of the hands through volumization and contouring. The extensive long-term safety outcomes reported with fillers and the ease with which they are administered make them an ideal choice to correct rhytides and to contour the face. However, as with any cosmetic procedure, in order to ensure high patient satisfaction and a safe outcome, proper training in injection techniques, the choice of the proper candidate, and awareness of potential adverse events are essential. This review article focuses on the permanent filler, Aquamid, which is composed of polyacrylamide hydrogel.

摘要

在过去的十年中,已经开发出了大量的软组织填充剂来纠正光老化引起的皮肤变化。这些填充物,无论是非永久性、半永久性还是永久性的,都被广泛用于填充不理想的面部皱纹。此外,填充物还被用于通过填充和塑形来纠正面部和身体其他部位(如手部背部)的萎缩。大量长期的安全性结果表明,填充物不仅安全,而且易于管理,是纠正皱纹和塑造面部的理想选择。然而,与任何美容程序一样,为了确保患者高度满意和安全的结果,注射技术的适当培训、合适候选人的选择以及对潜在不良反应的认识是必不可少的。本文主要关注由聚丙烯酰胺水凝胶组成的永久性填充剂 Aquamid。